ORIGINAL RESEARCH
Published on 11 Sep 2026
γδ T-cell interferon-γ production reflects metabolic improvement during SGLT2 inhibitor-based therapy in type 2 diabetes
doi 10.3389/fendo.2026.1922668
- 663 views
Molecular Signatures of Peripheral Blood Mononuclear Cells in Type 1 and Type 2 Diabetes: Pathophysiological Mechanisms, Biomarkers, and Therapeutics
155
Total downloads
3,945
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: